According to a new report published by Allied Market Research, titled, “Medical Cannabis, by Product Type, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021–2030,” the global medical cannabis market size was valued at $6.82 Billion in 2020 and is projected to reach $53.85 Billion by 2030 registering a CAGR of 23.60% from 2021 to 2030.
♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞:
https://www.alliedmarketresearch.com/request-sample/14619
Key Findings of the Study –
- Depending on product type, the cannabis extract held largest share in the global medical cannabis market in 2020.
- On the basis of application, the chronic pain was the major shareholder in 2020, and is expected to remain dominant throughout the forecast period.
- By end user, the pharmaceutical dominated the global medical cannabis market in 2020 and is anticipated to continue this trend during the forecast period.
- Region wise, North America is expected to experience growth at the highest rate, registering a CAGR of 21.20% during the forecast period.
Doctors prescribe medical cannabis, also known as medical marijuana (MMJ), for the treatment of various diseases, including chronic pain, cancer, depression, diabetes, arthritis, glaucoma, epilepsy, migraines, AIDS and Alzheimer’s disease. The use of cannabis as a medicine has not been rigorously tested due to production and government restrictions, resulting in limited clinical research to explain the safety and efficacy of using cannabis for treatment.
The regulation of cannabis in different regions and the increase of consumers about the health benefits of cannabis and its medical applications are growing, such as the treatment of various diseases and symptoms including cancer, chronic pain, depression Depression, arthritis, diabetes, glaucoma, migraines and epilepsy. multiple sclerosis, AIDS, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, post-traumatic stress disorder (PTSD), Parkinson’s disease and Tourette’s disease are the main drivers of the medical cannabis market. In addition, the development of new products with increasing R&D activity is driving the growth of the medicinal cannabis market.
♦ 𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/purchase-enquiry/14619
North America accounted for the largest share of the global medical cannabis market in 2020 and is expected to continue to dominate over the forecast period. This is due to the legalization of cannabis in the United States and Canada for health and recreation, the increase in the use of the drug to treat many diseases related to lifestyle changes such as chronic pain, depression, stress post-traumatic stress. Social anxiety, cancer, multiple sclerosis and epilepsy in North America.
Key Market Players –
Major key players that operate in the industry are Aurora marijuana Inc., Canopy Growth Corporation, Cronos Group Inc., Maricann Group, Inc., Medical Marijuana, Inc., OrganiGram Holding Inc., Terra Tech Corp., Tikun Olam Ltd., Tilray, Inc., and VIVO Cannabis Inc.
By Region –
North America (U.S., Canada, Mexico)
Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
♦ 𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐡𝐢𝐬 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/checkout-final/967bb821207b4f02368d61ce001c118f
Frequently Asked Questions?
Q1. What is the total market value of global medical cannabis market?
Q2. Which market holds the maximum market share of the global medical cannabis market?
Q3. What will be global medical cannabis market growth in 2030?
Q4. What are the key trends in the global medical cannabis market?
Q5. What are the key growth strategies of global medical cannabis market players? Q6. How the company profile has been selected?
About Us –
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com